Aivita Biomedical

Developer of dendritic cell immunotherapy for cancer and markets stem cells based facial serum for skin care

placeIrvine, California, United States calendar_todayFounded 2016 groups20 employees language aivitabiomedical.com

Registered entities

Innovation

5 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 452 times.

YearFilings
20182
20193
20203
20214
20223
20232
20243
20253

Social engagement

Social engagement: 2K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Array, California Technology Ventures.

Investor typeCountShare
Venture capital343%
Other / undisclosed457%

Recent activity

22 Jun 2026
Event
BIO International 2026
2 Jun 2026
Event
AIVITA's personalized DC-ATA cancer vaccine platform deep dive
17 Apr 2026
Event
UC Irvine Chief Executive Roundtable Entrepreneurship Forum
Coming soon